3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
3
Neoplasms
2
Thoracic Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Squamous Non Small Cell Lung Cancer
1
Solid Tumors
1
Solid Tumor, Adult
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasm Metastasis
1
Lung Diseases
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
pembrolizumab
7
Radiotherapy
3
Proton Therapy
3
Interleukin-2
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Rosuvastatin Calcium
2
Paclitaxel
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
tislelizumab
1
sotorasib
1
peposertib
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
leronlimab
1
lenvatinib
1
atezolizumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Solid Tumor, Adult
×
necitumumab
×
Clear all
NCT03360734
2021-07-12
GATTO
Glycotope GmbH
Phase 1
Completed
50 enrolled